September 01, 2026 article Vaccination anti-Ebola Revue Francophone des Laboratoires DOI: 10.1016/s1773-035x(26)76754-x OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 5 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial 2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents 173 citations Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial 2022 PLoS Medicine article Medicine Viral Infections and Outbreaks Research Open access 65 citations First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study 2022 PLoS ONE article Medicine Viral Infections and Outbreaks Research Open access 34 citations Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 2023 Clinical Microbiology and Infection article Medicine Viral Infections and Outbreaks Research Open access 27 citations Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases 2024 Nature Communications article Medicine Viral Infections and Outbreaks Research Open access 23 citations 5 results